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Abstract
Objective: To estimate the prevalence of undiagnosed depression in the 
diabetic clinic and factors that may indicate the presence of depression.
Materials and Methods: The Chinese version of the Beck Depression 
Inventory II (BDI-2) was used to assess the depressive symptoms of sub-
jects who attended the diabetes education program of a regional teaching 
hospital in Chiayi County, Taiwan. Correlation with patient characteristics, 
symptoms and laboratory data were compared.
Results: A total of 167 cases were analyzed. Twenty-two cases (13.17%) 
scored above or equal to 17, indicating at least mild depression. 
Multivariate logistic regression analysis showed that using injection to 
control blood glucose and total cholesterol levels were associated with 
higher BDI scores. Those who were told that they had heart disease and 
those who worked as manual laborers had less association with depression.
Conclusion: The prevalence of undetected depression is high among 
type 2 diabetics. Routine screening for depression during outpatient vis-
its is recommended. [Tzu Chi Med J 2008;20(1):44–48]
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1. Introduction
Diabetes mellitus is one of the chronic disorders that 
cause many symptoms and requires constant careful 
management by the patients themselves. It is gen-
erally agreed that people with diabetes have more 
depressive symptoms [1]. A recent meta-analysis 
reported a twofold higher odds of depression in indi-
viduals with diabetes compared to those without 
diabetes [2]. There are two hypotheses about this 
association. One is that diabetes mellitus and depres-
sion are linked biologically, that is, patients with 
depression are more prone to become diabetic, or 
vice versa. The other is that the association could be 
the result of the complexity of the disease itself and 
the associated comorbidity [3,4]. Depressive symp-
toms are more common in the medically ill than it 
is in the general population [5]. Patients’ subjective 
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symptom perception of diabetes is more related to 
depressed mood than to objective measures of 
blood glucose control [6]. Ludman et al showed that 
the total symptom burden of diabetes was corre-
lated with the number of depressive symptoms [7]. 
Several factors such as gender, being unmarried, low 
levels of education, higher number of comorbidi-
ties and complications, and the necessity of insulin 
treatment have been associated with higher inci-
dence of depression [8–11]. Treatment of depression 
with anti depressants was shown to improve glycemic 
control in some studies but the effects of cognitive 
behavior therapy appeared to have no such benefit 
[12–14]. Nonetheless, depressive symptoms are still 
not assessed routinely during the treatment course 
of our diabetic patients. The goal of this study was 
to examine the prevalence of undetected depres-
sive symptoms in Taiwanese type 2 diabetes patients 
and the factors that may be associated with such 
symptoms.
2. Materials and methods
The subjects consisted of 187 patients with diabe-
tes who attended the diabetes education program 
at Dalin Tzu Chi Hospital in 2006. Those who were 
less than 25 years of age, had experienced diabetic 
ketoacidosis in the past, had severe comorbidities of 
liver cirrhosis, end-stage kidney disease, ongoing can-
cer treatment, amputation or stroke were excluded. 
Those who were receiving treatment for depression 
were also intentionally left out. Appropriate consent 
forms were obtained from the participants.
The following information were obtained: age, 
sex, body mass index, marital status, educational 
status, occupation, living condition, duration of 
diabetes, type of oral agents used, type of insulin 
injection, number of injections per day, presence of 
retinopathy, neuropathy, proteinuria and number of 
comorbid chronic illnesses. The most recent labora-
tory data collected included: fasting blood glucose, 
total and low-density cholesterol, hemoglobin A1C, 
and systolic and diastolic blood pressures.
Questionnaires of the Chinese version of the Beck 
Depression Inventory II (BDI-2) were either com-
pleted by the patients themselves or, in the cases 
of illiterate patients and those with impaired vision, 
by our specially trained nurse assistant during inter-
view. This study was approved by the institutional 
review board of Dalin Tzu Chi General Hospital.
2.1. Statistical analysis
Data were analyzed using SAS version 9.1.3 (SAS 
Institute Inc., Cary, NC, USA). The odds ratios (ORs) 
of factors associated with depression as indicated by 
BDI-2 scores were estimated. In descriptive analysis, 
mean ± standard deviation (SD) was chosen for those 
data fitting the normal distribution, and median (first 
quartile, third quartile) for those not fitting the normal 
distribution (Table 1). Multiple logistic regression mod-
els were fitted to the collected data. In selecting the 
variables, the stepwise procedure was applied to logis-
tic regression analysis. The percentage of concordant 
pairs was 80.1. The p value of the Hosmer-Lemeshow 
goodness-of-fit test was 0.255. In all statistical test-
ing, a type 1 error of α = 0.05 was taken, thus p < 0.05 
indicated a statistically significant result.
3. Results
Of the 187 patients interviewed, 167 (89.3%) cases 
were included in the study. The demographic and 
clinical characteristics of the patients are listed in 
Table 1. The median BDI score was 6.0. There were 
35 (21.6%) cases with BDI score ≥ 14. A total of 22 
(13.17%) cases had BDI score ≥ 17, which was consid-
ered to be an indication of depression in the present 
study. This was chosen based on the study of Lu et al 
who suggested that BDI scores in the range of 0–16 
Table 1 — Demographic data*
Male 69 (41.3%)
Female 98 (58.7%)
Age (yr) 60.2 ± 11.0
Years of having DM 5.0 (2.0, 11.0)
Unemployed, retired or homemaker 112 (67.07%)
Blue collar worker 46 (27.54%)
White collar worker 9 (5.39%)
Methods of treatment
  Oral medications 130 (72.8%)
  Injection 12 (7.2%)
  Both 25 (15.0%)
BMI 25.6 (23.5, 27.9)
BDI  6.0 (3.0, 11.0)
AC sugar 140.5 (118.0, 177.0)
HbA1C 7.5 (6.8, 8.7)
TC 175.5 (154.0, 203.0)
TG 150.5 (103.0, 224.0)
HDL-C 50.0 (42.0, 59.0)
LDL-C 118.1 ± 34.4
*Data are presented as n (%), or mean ± standard deviation, or 
me dian (first quartile, third quartile). DM = diabetes mellitus; BMI  =  
body mass index; BDI  =  Beck Depression Inventory; HbA1C  =  gly-
cosylated hemoglobin; TC  =  total cholesterol; TG  =  triglycerides; 
HDL-C  =  high-density lipoprotein cholesterol; LDL-C  =  low-density lipo-
protein cholesterol.
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were considered to be not depressed in a sample of 
Taiwan’s psychiatric outpatient visitors [15].
Adjusted for the 2006 age distribution of the pop-
ulation of Taiwan, the prevalence rate of depression 
in the elderly (age ≥ 65) in our study population was 
16.6%.
Factors such as sex, age, hypertension, weight, 
marital status, occupation, number of years of hav-
ing diabetes, A1C level, triglyceride, and body mass 
index appeared not to have any correlation with BDI 
scores. The significant factors are listed in Table 2. 
On multivariate logistic regression, we extracted four 
factors that were associated with depression, namely 
total cholesterol levels, use of any form of injection 
to control diabetes, absence of heart disease, and 
not being a blue collar worker (Table 3). The OR for 
total cholesterol was 1.012 (95% confidence interval 
[CI], 1.002–1.023; p = 0.0245). The risk of depres-
sion rose as the level of total cholesterol increased. 
The odds for having depression appeared to favor 
those who used insulin injection to control diabe-
tes (OR, 4.126; 95% CI, 1.471–11.570; p = 0.007). 
Two factors were found to have a negative correla-
tion with depressive symptoms: those who were 
told that they had heart diseases (OR, 0.172; 95% 
CI, 0.036–0.832; p = 0.029) and those who were blue 
collar workers (OR, 0.093; 95% CI, 0.012–0.746; 
p = 0.025).
4. Discussion
The prevalence of undiagnosed depression in our 
sample population was 13.17%. The actual preva-
lence ought to be higher because of the following. 
First, in order to minimize the effect of psychoso-
cial stress caused by having diabetes, we limited our 
enrolment to those patients without complex comor-
bidities and complications. Second, we excluded 
patients with an established diagnosis of depression 
(ICD-9: 311). Third, a large proportion of the patients 
were illiterate and required interview by our nurse 
assistant. The scores obtained this way tend to be 
lower than that obtained when patients answer the 
questionnaires privately [16].
We also excluded patients who were less than 25 
years of age as they were more likely to have type 
1 diabetes, and those who were incapacitated due 
to diabetic complications as they were more likely 
to be depressed due to the severe comorbidities 
rather than to the diabetes per se. Those who had 
already been diagnosed with depression were also 
not included since they might already be under treat-
ment and their BDI scores might not be accurate in 
representing their underlying depression.
Our results showed that higher levels of total cho-
lesterol appeared to be related to the presence of 
Table 2 — Significant factors*
Variable BDI ≥ 17 (n = 22) BDI < 17 (n = 145) p
Age 59.5 ± 13.9 60.3 ± 10.6 0.725
Years of having DM 7.5 (3, 16) 5 (2,10) 0.196
AC sugar 154 (115, 173) 137 (118, 177) 0.298
HbA1C 7.4 (6.4, 9.1) 7.5 (6.8, 8.6) 0.802
TC 203 (156, 239) 174 (154, 197) 0.051
TG 172 (118, 249) 145.5 (101.5, 222.0) 0.348
HDL-C 51 (40, 63) 49 (42, 58) 0.440
LDL-C 114.2 ± 35.4 118.6 ± 34.4 0.601
Heart disease 2 (9.1%) 40 (27.6%) 0.047†
Blue collar 1 (4.5%) 45 (31.0%) 0.005†
Oral medications 11 (50.0%) 118 (81.4%) 0.002†
*Data of normal distribution are expressed as mean ± standard deviation and t test was used, data of not normal distribution are expressed 
as median (first quartile, third quartile) and Mann-Whitney U test was used, and χ2 or Fisher’s exact test was used for categorical data; 
†p < 0.05. BDI  =  Beck Depression Inventory; DM  =  diabetes mellitus; HbA1C  =  glycosylated hemoglobin; TC  =  total cholesterol; TG  =  triglycerides; 
HDL-C  =  high-density lipoprotein cholesterol; LDL-C  =  low-density lipoprotein cholesterol.
Table 3 — Factors associated with depression in the 
logistic model
 β OR 95% CI p
Intercept –2.555   0.022
Heart disease
  Yes –1.758 0.172 0.036–0.832 0.029
  No  Reference
Blue collar
  Yes –2.373 0.093 0.012–0.746 0.025
  No  Reference
Injections
  Yes 0.709 4.126 1.471–11.570 0.007
  No  Reference
TC* 0.012 1.012 1.002–1.023 0.0245
*This item was computed as a continuous variable. OR = odds ratio; 
CI = confidence interval; TC = total cholesterol.
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depression. Whether or not this is due to the fact that 
depressed patients are less vigorous in control-
ling their diabetes, we are not sure. On the other 
hand, some patients may find that controlling dia-
betes requires a major change in their lifestyle, and 
those with difficulty in doing so might get depressed. 
However, we could not find a significant association 
between depressive symptoms and glycohemoglobin 
levels in our study.
A study from Korea [10] found that patients who 
required insulin injection had a higher risk of being 
depressed. We found this to be the case in our study 
population as well. Daily injection may be perceived 
to be a chore and therefore causes more stress.
Diabetic patients who were told that they had 
heart disease appeared to have less tendency to have 
depressive symptoms. This is in contradiction to the 
belief that comorbidity tends to increase the odds of 
having depression. In the interview, the nature of the 
heart disease was not specified, although our inten-
tion was to pick up those diabetic patients who were 
also diagnosed with coronary artery disease. Further 
study may be necessary to confirm or refute this 
negative association.
Diabetic patients who worked as manual laborers 
appeared to have less association with depression. 
Since the majority of the non-blue-collar workers were 
actually unemployed or retired, being actively work-
ing may be the factor that had a negative correlation 
with depression.
As far as common diabetic symptoms are con-
cerned, none of the symptoms appeared to have 
significant correlation with depression. Those 
somatic symptoms that are common in people with 
either diabetes or depression (BDI items 15, 16, 18, 
20 and 21) would have a tendency to raise the BDI 
score in our population. However, due to the fact 
that we had chosen the higher BDI score of 17 as 
our cut-off for depression, this tendency might have 
been offset.
In conclusion, depression symptoms are fairly 
common in type 2 diabetics. Patients who have 
more diabetes-related symptoms may actually be 
depressed. We cannot state the causal direction 
of such an association. The combination of diabe-
tes with depression causes poorer glycemic control 
[17,18], poorer quality of life [19], higher cost of care 
[20,21], worse complications [22], more work loss 
and disability bed days [22], and even higher mortal-
ity [23]. Therefore, we recommend routine screening 
for depression in people with diabetes, especially 
during diabetic education classes when they can 
spend more time with the diabetes educators. We 
ought to pay more attention to those with higher 
total cholesterol levels, those who are not working or 
retired, and those who use injections to control their 
blood sugar.
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